Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page update adds new metadata and navigation references related to Gilead's clinical trials website, study documents, IPD planning, and publications, plus associated MeSH terms, enriching contextual references and external links for the Magrolimab study.SummaryDifference91%

- Check18 days agoChange DetectedCore study details and linked documents were removed, including intervention names, arms, and locations, along with several key study documents and metadata that described how the trial is organized and where it takes place.SummaryDifference20%

- Check25 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4. This indicates a minor patch to the page's versioning rather than a substantive content update.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded a new revision tag Revision: v3.6.3, replacing the previous Revision: v3.6.0. The change appears to be a minor page version update and does not affect the study details.SummaryDifference0.0%

- Check67 days agoChange DetectedRecruitment is now marked as closed ('No longer looking for participants'), signaling that the study is not accepting new participants. The changes also add navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and adjust the Intervention/Treatment heading formatting, with the footer revision tag updated to v3.6.0.SummaryDifference0.4%

- Check75 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, representing a new version of the page rather than a substantive change to study information.SummaryDifference0.0%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.